Genus PLC (LSE:GNS) - Share price - Overview

Stock Report

Genus PLC GNS

Last Price
GBX2,192.00

Day Change
-19.00|-0.86%

As of 17/11/2017
16:36:27 GMT | GBX
Minimum 15 Minutes Delay.

Last Close2,211.00p
Day Range2,190.00 - 2,237.00
Mkt Cap1.35Bil
52-Wk Range1,652.00 - 2,500.00
Yield %1.01
ISINGB0002074580
Volume26,320
P/E38.21
P/S2.91
P/CF34.79

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Genus PLC0.15 
FTSE 100 TR GBP-1.44
 
Financials
201520162017
More ...
Income Statement
Turnover398.50388.30459.10
Operating Profit59.5058.6038.20
Net Profit40.5050.3034.30
Reported EPS64.9080.3053.00
Balance Sheet
Current Assets179.50215.80225.50
Non Current Assets464.30523.00571.80
Total Assets644.30739.10797.60
Current Liabilities81.1077.4094.00
Total Liabilities339.20371.00395.50
Total Equity305.10368.10402.10
Cash Flow
Operating Cash Flow49.5043.4046.90
Net Change in Cash-0.8010.70-7.70
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201860.0171.8225.1930.521.2125.851.18
201966.6979.8811.2327.442.4428.391.30

Regulatory News

DateSourceHeadline
More ...
16/11/2017|14:49RNSGenus PLC - Result of AGM
16/11/2017|07:00RNSGenus PLC - AGM Trading Update
06/11/2017|12:48RNSGenus PLC - Director/PDMR Shareholding
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/04/2017in Lieu of DividendMr. Stephen Wilson1,803.0012216.00
13/12/2016in Lieu of DividendMr. Stephen Wilson1,806.2021379.00

Company Profile

Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.

Sector

Biotechnology

Market Position

248 of 1833 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE techMARK All Share ,FTSE techMARK Focus ,FTSE All Share

Outlook

(16/11/2017) "The board anticipates that Genus will perform in line with its growth expectations for the financial year 2018"

Next Event 01/12/2017

Dividend Payment
Ratios
CompSecMkt
More ...
PER (E)29.2613.6316.14
Div Yld (E)1.224.134.26
PEG (E)1.531.241.34
ROCE8.97180.3415.81
Op Mrgn8.56-8.42-9.53
EPS Grwth19.0812.8214.73
Dividends
PreviousLatest
More ...
Record Date03/03/1717/11/17
Ex-Div02/03/1716/11/17
Paid31/03/1701/12/17
Amnt7.4016.20

Broker Sentiment

Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Bob Lawson
Chief Executive OfficerKarim Bitar
Group Finance DirectorMr. Stephen Wilson
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.